SMT202000563T1 - Forem allo stato solido di sali di nilotinib - Google Patents
Forem allo stato solido di sali di nilotinibInfo
- Publication number
- SMT202000563T1 SMT202000563T1 SM20200563T SMT202000563T SMT202000563T1 SM T202000563 T1 SMT202000563 T1 SM T202000563T1 SM 20200563 T SM20200563 T SM 20200563T SM T202000563 T SMT202000563 T SM T202000563T SM T202000563 T1 SMT202000563 T1 SM T202000563T1
- Authority
- SM
- San Marino
- Prior art keywords
- solid state
- state forms
- nilotinib salts
- nilotinib
- salts
- Prior art date
Links
- 150000004930 Nilotinib derivatives Chemical class 0.000 title 1
- 239000007787 solid Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662307841P | 2016-03-14 | 2016-03-14 | |
| US201662418745P | 2016-11-07 | 2016-11-07 | |
| PCT/US2017/022072 WO2017160703A1 (en) | 2016-03-14 | 2017-03-13 | Solid state forms of nilotinib salts |
| EP17712404.7A EP3430004B1 (en) | 2016-03-14 | 2017-03-13 | Solid state forms of nilotinib salts |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SMT202000563T1 true SMT202000563T1 (it) | 2020-11-10 |
Family
ID=58361203
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SM20200563T SMT202000563T1 (it) | 2016-03-14 | 2017-03-13 | Forem allo stato solido di sali di nilotinib |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10640487B2 (it) |
| EP (1) | EP3430004B1 (it) |
| CY (1) | CY1123877T1 (it) |
| DK (1) | DK3430004T3 (it) |
| ES (1) | ES2814499T3 (it) |
| HR (1) | HRP20201470T1 (it) |
| HU (1) | HUE050890T2 (it) |
| LT (1) | LT3430004T (it) |
| PL (1) | PL3430004T3 (it) |
| PT (1) | PT3430004T (it) |
| RS (1) | RS60939B1 (it) |
| SI (1) | SI3430004T1 (it) |
| SM (1) | SMT202000563T1 (it) |
| WO (1) | WO2017160703A1 (it) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2017348665A1 (en) * | 2016-10-28 | 2019-05-02 | Apotex Inc. | Novel salts of nilotinib and crystalline forms thereof |
| EP3806858A4 (en) | 2018-06-15 | 2022-03-09 | Handa Pharmaceuticals, Inc. | KINA INHIBITOR SALTS AND COMPOSITIONS THEREOF |
| CN113573712A (zh) * | 2019-02-18 | 2021-10-29 | 斯莱班克制药有限责任公司 | 尼洛替尼的药物组合物 |
| CN114133378B (zh) * | 2020-09-04 | 2023-08-15 | 成都苑东生物制药股份有限公司 | 一种盐酸尼洛替尼共晶及其制备方法 |
| WO2022055836A1 (en) * | 2020-09-08 | 2022-03-17 | Teva Pharmaceuticals International Gmbh | Solid state forms of at-001 and process for preparation thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7135575B2 (en) * | 2003-03-03 | 2006-11-14 | Array Biopharma, Inc. | P38 inhibitors and methods of use thereof |
| GT200600315A (es) | 2005-07-20 | 2007-03-19 | Formas cristalinas de 4-metilo-n-[3-(4-metilo-imidazol-1-ilo)-5-trifluorometilo-fenilo]-3-(4-pyridina-3-ilo-pirimidina-2-iloamino)-benzamida | |
| GT200600316A (es) | 2005-07-20 | 2007-04-02 | Sales de 4-metilo-n-(3-(4-metilo-imidazol-1-ilo)-5-trifluorometilo-fenilo)-3-(4-piridina-3-ilo-pirimidina-2-iloamino)- benzamida. | |
| EP2530081A3 (en) | 2008-11-05 | 2013-04-10 | Teva Pharmaceutical Industries, Ltd. | Nilotinib HCI crystalline forms |
| KR20130042498A (ko) | 2010-06-21 | 2013-04-26 | 테바 파마슈티컬 인더스트리즈 리미티드 | 닐로티닙 염 및 이의 결정형 |
| KR20150068483A (ko) | 2012-10-19 | 2015-06-19 | 바스프 에스이 | 닐로티닙 및 선택된 공-결정 형성제를 포함하는 다성분 결정질 시스템 |
-
2017
- 2017-03-13 SM SM20200563T patent/SMT202000563T1/it unknown
- 2017-03-13 HU HUE17712404A patent/HUE050890T2/hu unknown
- 2017-03-13 RS RS20201105A patent/RS60939B1/sr unknown
- 2017-03-13 US US16/084,357 patent/US10640487B2/en active Active
- 2017-03-13 PT PT177124047T patent/PT3430004T/pt unknown
- 2017-03-13 EP EP17712404.7A patent/EP3430004B1/en active Active
- 2017-03-13 WO PCT/US2017/022072 patent/WO2017160703A1/en not_active Ceased
- 2017-03-13 HR HRP20201470TT patent/HRP20201470T1/hr unknown
- 2017-03-13 DK DK17712404.7T patent/DK3430004T3/da active
- 2017-03-13 LT LTEP17712404.7T patent/LT3430004T/lt unknown
- 2017-03-13 SI SI201730428T patent/SI3430004T1/sl unknown
- 2017-03-13 ES ES17712404T patent/ES2814499T3/es active Active
- 2017-03-13 PL PL17712404T patent/PL3430004T3/pl unknown
-
2020
- 2020-09-09 CY CY20201100855T patent/CY1123877T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RS60939B1 (sr) | 2020-11-30 |
| CY1123877T1 (el) | 2022-03-24 |
| SI3430004T1 (sl) | 2021-03-31 |
| LT3430004T (lt) | 2020-11-25 |
| PL3430004T3 (pl) | 2021-01-25 |
| DK3430004T3 (da) | 2020-09-28 |
| US20190071426A1 (en) | 2019-03-07 |
| ES2814499T3 (es) | 2021-03-29 |
| HUE050890T2 (hu) | 2021-01-28 |
| EP3430004B1 (en) | 2020-07-15 |
| US10640487B2 (en) | 2020-05-05 |
| PT3430004T (pt) | 2020-08-21 |
| EP3430004A1 (en) | 2019-01-23 |
| WO2017160703A1 (en) | 2017-09-21 |
| HRP20201470T1 (hr) | 2020-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL287437A (en) | Flavociclib solid dosage forms | |
| HUE057055T2 (hu) | Lumateperon-ditozilátsó szilárd halmazállapotú formái | |
| SG11201706729SA (en) | Derivatives of sobetirome | |
| IL257026A (en) | Solid state forms of eluxadoline | |
| IL258254B (en) | Salts and solid forms of the antibiotic monobactam | |
| SMT202100551T1 (it) | Derivati di sobetirome | |
| SI3154526T1 (sl) | Trdne oblike sofosbuvira | |
| IL265628A (en) | Solid state forms of valbenazine | |
| SI3380554T2 (sl) | Kristalne oblike per-kloro-gama-ciklodekstrinov | |
| IL246979A0 (en) | Crystalline forms of sofosbuvir | |
| SG10202101979TA (en) | Crystalline forms of c21h22ci2n4o2 | |
| ZA201706282B (en) | Solid forms of menaquinols | |
| PT3430004T (pt) | Formas em estado sólido de sais de nilotinib | |
| HUE066360T2 (hu) | Eravaciklin kristályformái | |
| IL263673A (en) | Solid state forms of spiro-oxindole compounds | |
| PL3189045T3 (pl) | Nowe sole nilotynibu i jego polimorfy | |
| HUP1600030A2 (en) | Baricitinib salts | |
| IL253479A0 (en) | Crystalline forms of efinconazole | |
| IL246569A0 (en) | Solid forms of tenofovir | |
| IL254666A0 (en) | Crystalline forms of Aldecalcitol | |
| HUP1500506A2 (en) | Salts of palbociclib | |
| SG11201708527RA (en) | Manufacture of organopolysulfides and salts thereof | |
| IL249332A0 (en) | Crystalline forms of sofosbuvir | |
| GB201621771D0 (en) | New salts of compounds and uses thereof |